Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**Regeneration** is a natural biological process wherein organisms restore, replace, or regrow missing or damaged cellular structures, tissues, or organs. The process is central to the maintenance of tissues and organs across all species, but the extent and type of regeneration vary widely—from complete limb or organ regrowth in certain animals like salamanders and planarians, to limited tissue repair in humans (e.g., liver and skin)[1][2][3][8]. Key mechanisms include proliferation of stem or progenitor cells, dedifferentiation of mature cells, and the activation of specific genetic pathways such as Wnt/β-catenin[6]. While not a druggable molecular target, regeneration is the main focus of regenerative medicine—a field aiming to harness or mimic these natural processes in humans to treat injuries or degenerative conditions[2][8]. **Note:** "Regeneration" is a biological process, not a molecular target, receptor, enzyme, or other single molecular entity. Any attempt to use "Regeneration" as a therapeutic target identifier would be incorrect or misleading in biomedical data structuring.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Regeneration.